A detailed history of Wells Fargo & Company transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 26,079 shares of WVE stock, worth $169,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,079
Previous 18,259 42.83%
Holding current value
$169,774
Previous $92,000 73.91%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$3.54 - $6.84 $27,682 - $53,488
7,820 Added 42.83%
26,079 $160,000
Q4 2023

Feb 09, 2024

BUY
$4.16 - $6.87 $14,971 - $24,725
3,599 Added 24.55%
18,259 $92,000
Q3 2023

Nov 13, 2023

SELL
$3.56 - $5.75 $28,134 - $45,442
-7,903 Reduced 35.03%
14,660 $84,000
Q2 2023

Aug 15, 2023

BUY
$3.51 - $4.69 $77,655 - $103,761
22,124 Added 5039.64%
22,563 $82,000
Q1 2023

May 12, 2023

BUY
$3.58 - $6.3 $25 - $44
7 Added 1.62%
439 $1,000
Q4 2022

Feb 13, 2023

BUY
$3.18 - $7.0 $34 - $77
11 Added 2.61%
432 $3,000
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $220 - $398
93 Added 28.35%
421 $2,000
Q2 2022

Aug 12, 2022

SELL
$1.23 - $3.25 $5,136 - $13,572
-4,176 Reduced 92.72%
328 $1,000
Q1 2022

May 16, 2022

SELL
$2.0 - $3.28 $31,396 - $51,489
-15,698 Reduced 77.71%
4,504 $9,000
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $63,205 - $103,664
20,129 Added 27573.97%
20,202 $63,000
Q2 2021

Aug 16, 2021

SELL
$5.65 - $7.47 $127,430 - $168,478
-22,554 Reduced 99.68%
73 $0
Q1 2021

May 13, 2021

SELL
$5.61 - $12.01 $21,256 - $45,505
-3,789 Reduced 14.34%
22,627 $127,000
Q4 2020

Feb 09, 2021

BUY
$6.99 - $9.26 $84,509 - $111,953
12,090 Added 84.39%
26,416 $208,000
Q3 2020

Nov 05, 2020

SELL
$8.49 - $19.54 $23,890 - $54,985
-2,814 Reduced 16.42%
14,326 $122,000
Q2 2020

Aug 13, 2020

BUY
$7.44 - $11.29 $15,028 - $22,805
2,020 Added 13.36%
17,140 $178,000
Q1 2020

May 14, 2020

BUY
$6.94 - $14.22 $104,932 - $215,006
15,120 New
15,120 $142,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $565M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.